Personal information
Verified email domains
Biography
Dr. Gaspard Pardon graduated with a MSc in Microengineering from EPFL in 2008, and obtain his PhD in Electrical Engineering - Micro and Nanosystems from KTH Royal Institute of Technology in Stockholm, Sweden. His graduate research focussed on the engineering of novel micro- and nanofluidic devices and approaches for rapid Point-of-Care diagnostics of infectious diseases, including the detection of airborne pathogens.
In 2016, Gaspard moved to the Silicon Valley in California where he conducted postdocs at Stanford University. He worked on the development of novel in vitro cardiac models, a.k.a. organ-on-chip or microphysiological systems, using cardiac cells differentiated from human induced pluripotent stem cells (hiPSCs). He focussed his research and technological developments on the study of genetic cardiomyopathies, including Duchenne Muscular Dystrophy, studying the impact of tissue stiffness on cellular biomechanics, telomere shortening and disease progression.
Since March 2021, Gaspard joined EPFL Swiss Institute of Technology in Lausanne to establish and direct the Bioengineering and Organoids Technology platform at the AGORA Cancer Research Center. This hybrid platform aims to provide infrastructure and scientific support in the use, development and translation of bioengineering technologies. It fosters cross-disciplinary collaborations around bioengineering between the researchers from the partner institution: CHUV, HUG, UNIL, EPFL, Ludwig Cancer Research Center and ISREC, as well as with industrial partners in the biotech and pharma industry.
Activities
Employment (5)
Funding (7)
NDS-2021-906
18POST34080160